FDNA Stock

FDNA develops facial dysmorphology novel analysis technology solutions for healthcare professionals.

Sign up today and learn more about FDNA Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About FDNA Stock

FDNA develops facial dysmorphology novel analysis technology solutions for healthcare professionals. It offers a genetic search and reference tool called Face2Gene that facilitates detection of facial dysmorphic features and recognizable patterns of human malformations from a facial photo to present a list of matching syndromes with up-to-date references. FDNA's solution enables users to upload photos, search and review genetic resources, and analyze results and offers customized reports and visualization tools. Lior Wolf and Moti Shniberg founded it in 2011, with its headquarters in Boston in Massachusetts.

Management

Chief Scientific Advisor & Co-founder

Lior Wolf

CEO

Dekel Gelbman

Chairman & Co-founder

Moti Shniberg

Press

onartificialintelligence - May, 16 2017

Facial analysis can reveal rare diseases

jwtintelligence - Apr, 28 2017

Selfie healthcare

technologyreview - Apr, 28 2017

Diagnosing Disease with a Snapshot

octavianreport - Apr, 28 2017

Facing the Future

genomeweb - Apr, 28 2017

FDNA Face2Gene Research Application

youtu - Jun, 19 2014

Face2Gene Tutorial

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo